Literature DB >> 6605144

Patterns of illness in an infant population in a poor socio-economic status multi-ethnic municipality.

A Carmichael, H E Williams.   

Abstract

The prevalence and patterns of illness and behavioural disturbances in a birth cohort of 273 infants followed longitudinally are reported. Four percent of infants showed serious morbidity, due to congenital abnormality, chronic illness or gross psychosocial disturbance in the family. Episodic and continuing or recurrent illness was common, but caused little serious morbidity and did not impair growth. Behavioural disturbances manifested by feeding, crying and sleeping difficulties were also common, 22% of all infants being moderately affected and 13% severely affected. Mothers were more concerned by these disturbances than by organic illness. The findings of illness in infants in this study were similar to those of a recent New Zealand study but differ from older overseas studies in which serious infective illness with high mortality was much more common. It is probable that these differences are largely explained by improvement in living conditions.

Entities:  

Mesh:

Year:  1983        PMID: 6605144     DOI: 10.1111/j.1440-1754.1983.tb02060.x

Source DB:  PubMed          Journal:  Aust Paediatr J        ISSN: 0004-993X


  3 in total

1.  Factors influencing mothers' decisions to consult a general practitioner about their children's illnesses.

Authors:  L M Osman; D Dunt
Journal:  Br J Gen Pract       Date:  1995-06       Impact factor: 5.386

2.  Late morbidity of very low birthweight infants.

Authors:  M E Imogen Morgan
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-20

Review 3.  Longitudinal Intergenerational Birth Cohort Designs: A Systematic Review of Australian and New Zealand Studies.

Authors:  Michelle L Townsend; Angelique Riepsamen; Christos Georgiou; Victoria M Flood; Peter Caputi; Ian M Wright; Warren S Davis; Alison Jones; Theresa A Larkin; Moira J Williamson; Brin F S Grenyer
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.